Companies will now be in the process of assessing the impact of the industry's new agreements on their portfolio of already reimbursed medicines and even their late-stage pipelines. …
Companies assess price cut impact and look ahead to April 2023
September 13, 2021 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Injunction blocks generic launch of key HIV combination medicine
August 6, 2026 - - Latest News -
Moderna begins Phase 1 trial of vaccine candidate against Bundibugyo Ebola Virus
August 6, 2026 - - Latest News -
Neuren reports record DAYBUE sales as royalties rise and global expansion nears
August 6, 2026 - - Australian Biotech -
NSW urged to think pharmacy first as 250 pharmacists near completion of advanced training
August 6, 2026 - - Latest News -
If Australian companies shun their domestic market, who can blame multinationals?
August 6, 2026 - - Latest News -
The complete absence of patient power and agency makes this a health system outlier
August 4, 2026 - - Latest News -
Pharmac announces plan to revise its recently expanded patient advisory function
August 4, 2026 - - Latest News